BACKGROUND/AIMS: To confirm in a cohort recruited in 1999-2001 our finding in a cohort recruited in 1992-1994 relating type 2 diabetes (T2D) to late-onset Alzheimer's disease (LOAD). METHODS: Participants were 1,488 persons aged 65 years and older without dementia at baseline from New York City. T2D was ascertained by self-report. Dementia and LOAD were ascertained by standard research procedures. Proportional hazard regression was used for analyses relating T2D and LOAD. RESULTS: The prevalence of T2D was 17%. There were 161 cases of dementia and 149 cases of LOAD. T2D was related to dementia (hazard ratio = 1.7; 95% confidence interval = 1.4-2.9) and LOAD (1.6; 1.0-2.6) after adjustment for age, sex, education, ethnic group and apolipoprotein E ε4. This association was weaker when only AD - excluding cases of mixed dementia - was considered (hazard ratio = 1.3; 95% confidence interval = 0.8-2.2). CONCLUSION: T2D is associated with LOAD. Cerebrovascular disease may be an important mediator.
BACKGROUND/AIMS: To confirm in a cohort recruited in 1999-2001 our finding in a cohort recruited in 1992-1994 relating type 2 diabetes (T2D) to late-onset Alzheimer's disease (LOAD). METHODS:Participants were 1,488 persons aged 65 years and older without dementia at baseline from New York City. T2D was ascertained by self-report. Dementia and LOAD were ascertained by standard research procedures. Proportional hazard regression was used for analyses relating T2D and LOAD. RESULTS: The prevalence of T2D was 17%. There were 161 cases of dementia and 149 cases of LOAD. T2D was related to dementia (hazard ratio = 1.7; 95% confidence interval = 1.4-2.9) and LOAD (1.6; 1.0-2.6) after adjustment for age, sex, education, ethnic group and apolipoprotein E ε4. This association was weaker when only AD - excluding cases of mixed dementia - was considered (hazard ratio = 1.3; 95% confidence interval = 0.8-2.2). CONCLUSION: T2D is associated with LOAD. Cerebrovascular disease may be an important mediator.
Authors: Rosebud O Roberts; Yonas E Geda; David S Knopman; Teresa J H Christianson; V Shane Pankratz; Bradley F Boeve; Adrian Vella; Walter A Rocca; Ronald C Petersen Journal: Arch Neurol Date: 2008-08
Authors: M E Risner; A M Saunders; J F B Altman; G C Ormandy; S Craft; I M Foley; M E Zvartau-Hind; D A Hosford; A D Roses Journal: Pharmacogenomics J Date: 2006-01-31 Impact factor: 3.550
Authors: Melissa Lamar; Donghong Wu; Ramon A Durazo-Arvizu; Adam M Brickman; Hector M Gonzalez; Wassim Tarraf; Martha L Daviglus Journal: Am J Hypertens Date: 2017-06-01 Impact factor: 2.689
Authors: Dana M Niedowicz; Christa M Studzinski; Adam M Weidner; Thomas L Platt; Kristen N Kingry; Tina L Beckett; Annadora J Bruce-Keller; Jeffrey N Keller; M Paul Murphy Journal: Biochim Biophys Acta Date: 2012-12-26
Authors: John M Ringman; Michael C Sachs; Yan Zhou; Sarah E Monsell; Jeffrey L Saver; Harry V Vinters Journal: JAMA Neurol Date: 2014-07-01 Impact factor: 18.302
Authors: Jill K Morris; Eric D Vidoni; Jonathan D Mahnken; Robert N Montgomery; David K Johnson; John P Thyfault; Jeffrey M Burns Journal: Neurobiol Aging Date: 2015-12-01 Impact factor: 4.673